Snowball logo
logo
ADAP_logo

Adaptimmune Therapeutics Plc

$0.055$0.00  (0%)

Frequently asked questions

What sector does Adaptimmune Therapeutics Plc (ADAP) operate in?

Adaptimmune Therapeutics Plc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Adaptimmune Therapeutics Plc (ADAP) current stock price?

As of the latest data, Adaptimmune Therapeutics Plc stock price is $0.06, with a previous close of $0.06.

What is Adaptimmune Therapeutics Plc (ADAP) current market capitalization?

Adaptimmune Therapeutics Plc market cap is approximately 14.58 million.

What is Adaptimmune Therapeutics Plc (ADAP) Earnings Per Share (EPS)?

The trailing EPS is -$0.66, and the forward EPS is -$0.50.

Does Adaptimmune Therapeutics Plc (ADAP) pay dividends?

No. Adaptimmune Therapeutics Plc does not pay a dividend.

What is Adaptimmune Therapeutics Plc (ADAP) beta (volatility) score?

Adaptimmune Therapeutics Plc has a beta of 2.492, indicating very high volatility compared to the market.